Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Anagenics ( (AU:AN1) ) has issued an announcement.
Anagenics Limited reported a significant improvement in operating cash flows for the quarter ended June 30, 2025, attributed to a successful business restructuring. The company’s Flouf Factor Growth Tonic has performed well, exceeding sales expectations and potentially generating higher royalties in FY2026. Anagenics is also in discussions with Roquefort Therapeutics regarding midkine antibody licensing. The company believes it has sufficient funds to support operations for the next two quarters without additional equity funding.
More about Anagenics
Anagenics Limited is a company operating in the haircare industry, focusing on products like the Bouf Haircare line. The company is exploring growth opportunities, including potential international market expansion, and is involved in discussions regarding midkine antibody licensing.
Current Market Cap: A$2.48M
For a thorough assessment of AN1 stock, go to TipRanks’ Stock Analysis page.